{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:02:21Z","timestamp":1791655341015,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Drug Innovation Major Project","award":["2018ZX09711001"],"award-info":[{"award-number":["2018ZX09711001"]}]},{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"crossref","award":["2016\u2013I2M\u20133\u2013009"],"award-info":[{"award-number":["2016\u2013I2M\u20133\u2013009"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejmech.2020.112315","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T11:23:59Z","timestamp":1592997839000},"page":"112315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Structure\u2013activity relationship and hypoglycemic activity of tricyclic matrines with advantage of treating diabetic nephropathy"],"prefix":"10.1016","volume":"201","author":[{"given":"Sheng","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying\u2013Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian\u2013Yu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan\u2013Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2013Dong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan\u2013Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei\u2013Jia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan\u2013Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112315_bib1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(16)30163-5","article-title":"Trends in diabetes: sounding the alarm","volume":"387","author":"Krug","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112315_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/1753-0407.12913","article-title":"Diabetes in developing countries","volume":"11","author":"Misra","year":"2019","journal-title":"J.\u00a0Diabetes"},{"key":"10.1016\/j.ejmech.2020.112315_bib3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/dc16-0157","article-title":"Clinical outcomes of metabolic surgery: microvascular and macrovascular complications","volume":"39","author":"Adams","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2020.112315_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7861\/clinmed.2019-0318","article-title":"Management of type 2 diabetes: now and the future","volume":"19","author":"Edeghere","year":"2019","journal-title":"Clin. Med. (Lond)"},{"key":"10.1016\/j.ejmech.2020.112315_bib5","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2174\/1381612821666150710145753","article-title":"Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism","volume":"21","author":"Meneses","year":"2015","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2020.112315_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/14740338.2019.1626823","article-title":"An update on the safety and efficacy of oral antidiabetic drugs: DPP-4 inhibitors and SGLT-2 inhibitors","volume":"18","author":"Lamos","year":"2019","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2020.112315_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2146\/ajhp110221","article-title":"Liraglutide-associated acute pancreatitis","volume":"69","author":"Knezevich","year":"2012","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ejmech.2020.112315_bib8","first-page":"647","article-title":"Hypoglycemic side effects of sulfonylureas and repaglinide in ageing patients-knowledge and self-management","volume":"69","author":"Harsch","year":"2018","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112315_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.mayocp.2019.01.004","article-title":"Metformin and sulfonylurea use and risk of incident dementia","volume":"94","author":"Scherrer","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejmech.2020.112315_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/jm101325h","article-title":"Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70","volume":"54","author":"Gao","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.23766","article-title":"Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA","volume":"52","author":"Peng","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2020.112315_bib12","doi-asserted-by":"crossref","DOI":"10.1021\/jm801157z","article-title":"Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy","volume":"52","author":"Li","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ejmech.2017.12.002","article-title":"Discovery and evolution of aloperine derivatives as a new family of HCV inhibitors with novel mechanism","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejmech.2018.02.061","article-title":"Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage","volume":"149","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/ml500525s","article-title":"Novel N-benzenesulfonyl sophocarpinol derivatives as coxsackie B virus inhibitors","volume":"6","author":"Tang","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112315_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/fmc-2015-0019","article-title":"SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors","volume":"8","author":"Tang","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/cmdc.201300224","article-title":"Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors","volume":"8","author":"Gao","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112315_bib18","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1016\/j.bmcl.2011.06.071","article-title":"structure-activity relationship and biological evaluation of novel N-substituted matrinic acid derivatives as host heat-stress cognate 70 (Hsc70) down-regulators","volume":"21","author":"Du","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112315_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4155\/fmc-2017-0081","article-title":"How can tricyclic sophoridinic derivatives be used as autophagy inhibitors for cancer treatments?","volume":"9","author":"Wang","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2014.04.069","article-title":"Novel N-substituted sophoridinol derivatives as anticancer agents","volume":"81","author":"Bi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112315_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/acsmedchemlett.6b00466","article-title":"Biological evaluation, and autophagy mechanism of 12N-substituted sophoridinamines as novel anticancer agents","volume":"8","author":"Bi","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112315_bib22","doi-asserted-by":"crossref","first-page":"E1644","DOI":"10.3390\/molecules23071644","article-title":"Discovery of matrinic thiadiazole derivatives as a novel family of anti-liver fibrosis agents via repression of the TGF\u03b2\/Smad pathway","volume":"23","author":"Niu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112315_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00894-008-0269-0","article-title":"Hydroxy-1,2,5-oxadiazolyl moiety as bioisoster of the carboxy function. A computational study on aminobutyric acid (gaba) related compounds","volume":"14","author":"Tosco","year":"2008","journal-title":"J.\u00a0Mol. Model."},{"key":"10.1016\/j.ejmech.2020.112315_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/1753-0407.12140","article-title":"Effects of rosiglitazone (PPAR \u03b3 agonist) on the myocardium in non-hypertensive diabetic rats (PPAR \u03b3)","volume":"7","author":"Abou Daya","year":"2015","journal-title":"J.\u00a0Diabetes"},{"key":"10.1016\/j.ejmech.2020.112315_bib25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0002-9440(10)63225-7","article-title":"Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1\/2 MAP kinase signaling pathway","volume":"164","author":"Li","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2020.112315_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.2006.02614.x","article-title":"The long-term effects of rosiglitazone on serum lipid concentrations and body weight","volume":"65","author":"Shim","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ejmech.2020.112315_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2362.2003.01178.x","article-title":"Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation","volume":"33","author":"Hutley","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2020.112315_bib28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1080\/08860220802389342","article-title":"The effects of spironolactone on nephron function in patients with diabetic nephropathy","volume":"30","author":"Ustundag","year":"2008","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejmech.2020.112315_bib29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.53.4.1052","article-title":"Like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?","volume":"53","author":"Brunmair","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2020.112315_bib30","first-page":"409","article-title":"Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells","volume":"38","author":"Xie","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2020.112315_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-981-10-7757-9_7","article-title":"Mitochondrial respiratory chain complexes","volume":"87","author":"Sousa","year":"2018","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2020.112315_bib32","article-title":"Berberine promotes glucose consumption independently of AMP-activated protein kinase activation","volume":"9","author":"Xu","year":"2014","journal-title":"PloS One"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420302841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:13:16Z","timestamp":1759327996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420302841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":32,"alternative-id":["S0223523420302841"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112315","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure\u2013activity relationship and hypoglycemic activity of tricyclic matrines with advantage of treating diabetic nephropathy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112315"}}